Bath & Body Works (NYSE:BBWI) Receives Neutral Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their neutral rating on shares of Bath & Body Works (NYSE:BBWI) in a report released on Monday, Marketbeat Ratings reports. The firm currently has a $26.00 target price on the stock.

Several other brokerages also recently weighed in on BBWI. UBS Group lowered their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research report on Friday, September 12th. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Citigroup dropped their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a report on Tuesday, August 19th. Finally, Barclays raised their price target on Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a report on Friday, August 29th. Eleven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $38.15.

Bath & Body Works Stock Performance

NYSE BBWI opened at $26.42 on Monday. The business’s fifty day moving average is $28.33 and its 200 day moving average is $29.43. Bath & Body Works has a fifty-two week low of $24.93 and a fifty-two week high of $41.87. The company has a market capitalization of $5.45 billion, a PE ratio of 7.84, a price-to-earnings-growth ratio of 0.88 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the company earned $0.37 earnings per share. The business’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts forecast that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. Bath & Body Works’s dividend payout ratio is presently 23.74%.

Institutional Trading of Bath & Body Works

A number of large investors have recently added to or reduced their stakes in BBWI. Stonehage Fleming Financial Services Holdings Ltd bought a new position in shares of Bath & Body Works during the 2nd quarter valued at approximately $33,000. SVB Wealth LLC purchased a new stake in Bath & Body Works during the first quarter valued at $35,000. Geneos Wealth Management Inc. lifted its position in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC lifted its position in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares during the last quarter. Finally, Golden State Wealth Management LLC lifted its position in Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.